A Shorter Regimen for Rifampin-Resistant Tuberculosis. Reply

Affiliations

¹ Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom a.nunn@ucl.ac.uk.
² UCSF Center for Tuberculosis, San Francisco, CA.

Comment

Andrew J Nunn et al. N Engl J Med. 2019.

. 2019 Sep 12;381(11):e22.

doi: 10.1056/NEJMc1905782.

¹ Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom a.nunn@ucl.ac.uk.
² UCSF Center for Tuberculosis, San Francisco, CA.

No abstract available

Comment on

A Shorter Regimen for Rifampin-Resistant Tuberculosis.
McCaw ZR, Meng Z, Wei LJ. McCaw ZR, et al. N Engl J Med. 2019 Sep 12;381(11):e22. doi: 10.1056/NEJMc1905782. N Engl J Med. 2019. PMID: 31509686 No abstract available.
A Shorter Regimen for Rifampin-Resistant Tuberculosis.
Tornheim JA, Udwadia ZF, Gupta A. Tornheim JA, et al. N Engl J Med. 2019 Sep 12;381(11):e22. doi: 10.1056/NEJMc1905782. N Engl J Med. 2019. PMID: 31509687 No abstract available.